Previous 10 | Next 10 |
home / stock / hmtxf / hmtxf news
Calgary, Alberta--(Newsfile Corp. - May 16, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (" Hemostemix " or the " Company ") is pleased to announce Mr. Richard ("Rick") Groome has joined Hemostemix as a special advisor to the CEO, focused on completing a series of financ...
Calgary, Alberta--(Newsfile Corp. - May 10, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (" Hemostemix " or the " Company ") is pleased to announce it has settled all litigation with, and closed the settlement agreement with, Aspire Health Services, Inc., AJIA Global, LLC and...
Calgary, Alberta--(Newsfile Corp. - April 25, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (" Hemostemix " or the " Company ") is pleased to announce that it has closed its previously announced $2,750,000 non-brokered secured convertible debenture unit offering (the " Debentu...
Calgary, Alberta--(Newsfile Corp. - April 12, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce that, further to its March 23, 2022 news release, Hemostemix has completed the audit of its ACP-01 clinical trial d...
Calgary, Alberta--(Newsfile Corp. - March 23, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce that it has entered into a settlement agreement (the " Settlement Agreement ") with Aspire Health Science, LLC (" Aspire ...
Calgary, Alberta--(Newsfile Corp. - March 3, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce that it will pay interest of $84,804.40 by issuing 446,339 Common Shares, using the March 2, 2022 closing price of $0.19 per sh...
Calgary, Alberta--(Newsfile Corp. - March 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce that it has signed a binding term sheet for a private placement of convertible debentures in the amount of $2,549,000, and...
Calgary, Alberta--(Newsfile Corp. - March 1, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (" Hemostemix " or the " Company ") is pleased to announce that in accordance with its stock option plan, it has granted on February 28, 2022, subject to regulatory approval, a total of ...
Calgary, Alberta--(Newsfile Corp. - February 28, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (" Hemostemix " or the " Company ") announces that it has closed its previously announced non-brokered private placement of units (" Units ") announced on February 2, 2022, for gross proceeds of...
Calgary, Alberta--(Newsfile Corp. - February 14, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce "Your Fountain of Youth" has been trademarked by the Company's intellectual property holding company, Kwalata Trading Limit...
News, Short Squeeze, Breakout and More Instantly...
Calgary, Alberta--(Newsfile Corp. - June 11, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it was notified by the World Intellectual Property Organization that it was granted the trademark Your Fountain of Youth by the Swiss Trademark Office. "In four h...
2024-06-03 13:23:23 ET In a press release this morning, %Hemostemix Inc. (TSXV: $HEM) (OTC: $HMTXF) announced it had signed a Letter of Intent ("LOI") with CytoImmune Therapeutics. The LOI will re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art clinical cell manu...
Calgary, Alberta--(Newsfile Corp. - June 3, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to announce it has signed a Letter of Intent ("LOI") with CytoImmune Therapuetics ("CytoImmune") to re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art c...